TestLine Clinical Diagnostics
High-Throughput Multiplex Diagnostics
TestLine Clinical Diagnostics - Revolutionizing Multiplex Diagnostics with Microblot-Array
Microblot–Array (MBA) represents a major advancement in multiplex diagnostics. Developed by TestLine Clinical Diagnostics s.r.o., this format replaces traditional BLOT strips with immunoarrays embedded directly into standard 96-well microtiter plates. It enables the simultaneous detection of multiple markers within a single well—supporting higher throughput, reduced material consumption, and greater efficiency in diagnostic workflows.
To meet the demands of producing these high-density, multi-parameter assays, TestLine relies on the iONE systems from M2-Automation. These non-contact dispensers offer the precision, flexibility, and stability required for arraying complex reagent patterns with sub-nanoliter accuracy, ensuring reproducibility and batch-to-batch consistency.
Depending on assay design, TestLine applies both "Spot and Stop" and "On-the-fly" dispensing techniques. This versatility allows for optimized spot morphology and reagent placement, while supporting scalable production.
By integrating M2-Automation’s dispensing technology, TestLine has established a fully automated workflow—from array printing through to test evaluation—combining throughput with consistent quality in the manufacturing of Microblot–Array diagnostics.
About TestLine Clinical Diagnostics
Based in Brno, Czech Republic, TestLine Clinical Diagnostics s.r.o. is a leading manufacturer of in vitro diagnostic kits, with a portfolio of over 400 products. The company specializes in infectious serology and immunology, offering ELISA, BLOT, and now Microblot–Array tests. With more than 30 years of expertise, TestLine is recognized for its innovation and reliability in laboratory diagnostics.
